Impact of the human genome project on epidemiologic research

Epidemiologic Reviews

Volumn 19, Issue 1, 1997, Pages 3-13

  Ellsworth, Darrell L ^a,b   Hallman, D Michael ^a   Boerwinkle, Eric ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL MODEL; DIAGNOSTIC TEST; DNA SEQUENCE; EPIDEMIOLOGY; GENE ISOLATION; GENE MUTATION; GENETIC ASSOCIATION; GENETIC LINKAGE; HUMAN; INFORMATION PROCESSING; MEDICAL ETHICS; MEDICAL GENETICS; MEDICAL RESEARCH; MOLECULAR GENETICS; NONHUMAN; PRIORITY JOURNAL; REVIEW; SOCIAL ASPECT;

EID: 0030697944     PISSN: 0193936X     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.epirev.a017943     Document Type: Review

References (103)

1. Neel JV, Schull WJ. Human heredity. Chicago, IL: The University of Chicago Press, 1954.
2. Morton NE, Chung CS, eds. Genetic epidemiology. New York, NY: Academic Press, 1978.
3. Sing CF, Skolnick M, eds. Genetic analysis of common diseases: applications to predictive factors in coronary disease. New York, NY: Alan R Liss, 1979.
4. Khoury MJ, Beaty TH, Cohen BH. Fundamentals of genetic epidemiology. New York, NY: Oxford University Press, 1993.
5. Weiss KM. Genetic variation and human disease: principles and evolutionary approaches. Cambridge, United Kingdom: Cambridge University Press, 1993.
6. Kerem B, Rommens JM, Buchanan JA, et al. Identification of the cystic fibrosis gene: genetic analysis. Science 1989; 245:1073-80.
7. Riordan JR, Rommens JM, Kerem B, et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 1989;245:1066-73.
8. Rommens JM, Iannuzzi MC, Kerem B, et al. Identification of the cystic fibrosis gene: chromosome walking and jumping. Science 1989;245:1059-65.
9. Knudson AG Jr. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci U S A 1971;68:820-3.
10. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990;61:759-67.
11. Harris H. The principles of human biochemical genetics. 3rd rev ed. Amsterdam, The Netherlands: Elsevier/North-Holland Biomedical Press, 1980.
12. Green ED, Waterston RH. The Human Genome Project: prospects and implications for clinical medicine. JAMA 1991;266:1966-75.
13. Engel LW. The Human Genome Project: history, goals, and progress to date. Arch Pathol Lab Med 1993;117:459-65.
14. Olson MV. The Human Genome Project. Proc Natl Acad Sci USA 1993;90:4338-44.
15. Green ED, Cox DR, Myers RM. The Human Genome Project and its impact on the study of human disease. In: Scriver CR, Beaudet AL, Sly WS, et al., eds. The metabolic and molecular bases of inherited disease. Vol 1. 7th ed. New York, NY: McGraw-Hill, 1995:401-36
16. Morton NE. Parameters of the human genome. Proc Natl Acad Sci U S A 1991;88:7474-6.
17. Bishop JO. The gene numbers game. Cell 1974;2:81-6.
18. Nowak R. Mining treasures from "junk DNA." (News). Science 1994;263:608-10.
19. Cantor CR. Orchestrating the Human Genome Project. Science 1990;248:49-51.
20. Watson JD. The Human Genome Project: past, present, and future. Science 1990;248:44-9.
21. Understanding our genetic inheritance - The US Human Genome Project: the first five years, FY 1991-1995. Bethesda, MD: Department of Health and Human Services, Public Health Service, National Institutes of Health, National Center for Human Genome Research; and US Department of Energy, Office of Energy Research, Office of Health and Environmental Research, Human Genome Program, 1990.
22. Verkerk AJMH, Pieretti M, Sutcliffe JS, et al. Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell 1991;65:905-14.
23. Royer-Pokora B, Kunkel LM, Monaco AP, et al. Cloning the gene for an inherited human disorder - chronic granulomatous disease - on the basis of its chromosomal location. Nature 1986;322:32-8.
24. Weber JL, May PE. Abundant class of human DNA polymorphisms which can be typed using the polymerase chain reaction. Am J Hum Genet 1989;44:388-96.
25. Gyapay G, Morissette J, Vignal A, et al. The 1993-94 Généthon human genetic linkage map. Nat Genet 1994;7 (spec no):246-339.
26. Dib C, Fauré S, Fizames C, et al. A comprehensive genetic map of the human genome based on 5,264 microsatellites. Nature 1996;380:152-4.
27. Olson M, Hood L, Cantor C, et al. A common language for physical mapping of the human genome. Science 1989;245: 1434-5.
28. Hudson TJ, Stein LD, Gerety SS, et al. An STS-based map of the human genome. Science 1995;270:1945-54.
29. Adams MD, Kerlavage AR, Fleischmann RD, et al. Initial assessment of human gene diversity and expression patterns based upon 83 million nucleotides of cDNA sequence. Nature 1995;377(6547 Suppl):3-174.
30. Chen EY, Liao YC, Smith DH, et al. The human growth hormone locus: nucleotide sequence, biology, and evolution. Genomics 1989;4:479-97.
31. Martin-Gallardo A, McCombie WR, Gocayne JD, et al. Automated DNA sequencing and analysis of 106 kilobases from human chromosome 19q13.3. Nat Genet 1992;1:34-9.
32. Rowen L, Koop BF, Hood L. The complete 685-kilobase DNA sequence of the human β T cell receptor locus. Science 1996;272:1755-62.
33. Wilson RK, Chen C, Avdalovic N, et al. Development of an automated procedure for fluorescent DNA sequencing. Genomics 1990;6:626-34.
34. Adams MD, Fields C, Venter JC, eds. Automated DNA sequencing and analysis. London, United Kingdom: Academic Press, 1994.
35. Ju J, Glazer AN, Mathies RA. Energy transfer primers: a new fluorescence labeling paradigm for DNA sequencing and analysis. Nat Med 1996;2:246-9.
36. Barrell B. DNA sequencing: present limitations and prospects for the future. FASEB J 1991;5:40-5.
37. Hunkapiller T, Kaiser RJ, Koop BF, et al. Large-scale and automated DNA sequence determination. Science 1991;254: 59-67.
38. Pearson ML, Söil D. The Human Genome Project: a paradigm for information management in the life sciences. FASEB J 1991;5:35-9.
39. Smith RF. Perspectives: sequence data base searching in the era of large-scale genomic sequencing. Genome Res 1996; 6:653-60.
40. Boguski MS, Schuler GD. ESTablishing a human transcript map. Nat Genet 1995;10:369-71.
41. Online Mendelian Inheritance in Man (OMIM). Bethesda, MD: National Center for Biotechnology Information, National Library of Medicine (www.ncbi.nlm.nih.gov/Omim). Accessed 1996.
42. Ott J. Analysis of human genetic linkage. Baltimore, MD: Johns Hopkins University Press, 1991.
43. Weeks DE, Lange K. The affected-pedigree-member method of linkage analysis. Am J Hum Genet 1988;42:315-26.
44. Amos CI. Robust variance-components approach for assessing genetic linkage in pedigrees. Am J Hum Genet 1994;54: 535-43.
45. Risch N, Zhang H. Extreme discordant sib pairs for mapping quantitative trait loci in humans. Science 1995;268:1584-9.
46. DeFronzo RA, Bonadonna RC, Ferrannini E. Pathogenesis of NIDDM: a balanced overview. Diabetes Care 1992;15: 318-68.
47. Hanis CL, Boerwinkle E, Chakraborty R, et al. A genome-wide search for human non-insulin-dependent (type 2) diabetes genes reveals a major susceptibility locus on chromosome 2. Nat Genet 1996;13:161-6.
48. Greenberg DA. Linkage analysis of "necessary" disease loci versus "susceptibility" loci. Am J Hum Genet 1993;52: 135-43.
49. Spielman RS, McGinnis RE, Ewens WJ. Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 1993;52:506-16.
50. Thomson G. Mapping disease genes: family-based association studies. Am J Hum Genet 1995;57:487-98.
51. Collins FS. Positional cloning: let's not call it reverse anymore. (News). Nat Genet 1992;1:3-6.
52. Collins FS. Identifying human disease genes by positional cloning. Harvey Lect 1990-1991;86:149-64.
53. Collins FS. Positional cloning moves from perditional to traditional. Nat Genet 1995;9:347-50.
54. Boerwinkle E, Ellsworth DL, Hallman DM, et al. Genetic analysis of atherosclerosis: a research paradigm for the common chronic diseases. Hum MoL Genet 1996;5(spec no): 1405-10.
55. Bennett ST, Lucassen AM, Gough SCL, et al. Susceptibility to human type 1 diabetes at IDDM2 is determined by tandem repeat variation at the insulin gene minisatellite locus. Nat Genet 1995;9:284-92.
56. Kennedy GC, German MS, Ratter WJ. The minisatellite in the diabetes susceptibility locus IDDM2 regulates insulin transcription. Nat Genet 1995;9:293-8.
57. Berry R, Stevens TJ, Walter NAR, et al. Gene-based sequence-tagged-sites (STSs) as the basis for a human gene map. Nat Genet 1995;10:415-23.
58. Schuler GD, Boguski MS, Stewart EA, et al. A gene map of the human genome. Science 1996;274:540-6.
59. Bassett DE Jr, Boguski MS, Spencer F, et al. Comparative genomics, genome cross-referencing and XREFdb. Trends Genet 1995;11-.372-3.
60. Boguski MS, Lowe TMJ, Tolstoshev CM. dbEST - database for "expressed sequence tags". Nat Genet 1993;4:332-3.
61. Landegren U, ed. Laboratory protocols for mutation detection. Oxford, United Kingdom: Oxford University Press, 1996.
62. Orita M, Iwahana H, Kanazawa H, et al. Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc Natl Acad Sci U S A 1989;86:2766-70.
63. Brow MD, Oldenburg M, Lyamichev V, et al. Mutation detection by cleavase fragment length polymorphism analysis. Focus 1996;18:2-5.
64. Jin L, Underhill PA, Oefner PJ, et al. Systematic search for polymorphisms in the human genome using denaturing high-performance liquid chromatography (DHPLC). (Abstract). Am J Hum Genet 1995;57(suppl):A26.
65. Grompe M. The rapid detection of unknown mutations in nucleic acids. Nat Genet 1993;5:111-17.
66. Olson MV. A time to sequence. Science 1995;270:394-6.
67. Templeton AR, Boerwinkle E, Sing CF. A cladistic analysis of phenotypic associations with haplotypes inferred from restriction endonuclease mapping. I. Basic theory and an analysis of alcohol dehydrogenase activity in Drosophila. Genetics 1987;117:343-51.
68. Julier C, Lucassen A, Villedieu P, et al. Multiple DNA variant association analysis: application to the insulin gene region in type I diabetes. Am J Hum Genet 1994;55: 1247-54.
69. Sayle RA, Milner-White EJ. RASMOL: biomolecular graphics for all. Trends Biochem Sci 1995;20:374-6.
70. Green P, Lipman D, Hillier L, et al. Ancient conserved regions in new gene sequences and the protein databases. Science 1993;259:1711-16.
71. Fishel R, Lescoe M, Rao MRS, et al. The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell 1993;75:1027-38.
72. Piedrahita JA, Zhang SH, Hagaman JR, et al. Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells. Proc Natl Acad Sci U S A 1992;89:4471-5.
73. Rubin EM, Ishida BY, Clift SM, et al. Expression of human apolipoprotein A-I in transgenic mice results in reduced plasma levels of murine apolipoprotein A-I and the appearance of two new high density lipoprotein size subclasses. Proc Natl Acad Sci U S A 1991;88:434-8.
74. Schultz JR, Rubin EM. The properties of HDL in genetically engineered mice. Curr Opin Lipidol 1994;5:126-37.
75. Smithies O, Maeda N. Gene targeting approaches to complex genetic diseases: atherosclerosis and essential hypertension. Proc Natl Acad Sci U S A 1995;92:5266-72.
76. Zhang SH, Reddick RL, Piedrahita JA, et al. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science 1992;258:468-71.
77. Schultz JR, Verstuyft JG, Gong EL, et al. Protein composition determines the anti-atherogenic properties of HDL in transgenic mice. Nature 1993;365:762-4.
78. Warden CH, Hedrick CC, Qiao JH, et al. Atherosclerosis in transgenic mice overexpressing apolipoprotein A-II. Science 1993;261:469-72.
79. Antonarakis SE. Diagnosis of genetic disorders at the DNA level. N Engl J Med 1989;320:153-63.
80. Kawasaki ES. The polymerase chain reaction: its use in the molecular characterization and diagnosis of cancers. Cancer Invest 1992;10:417-29.
81. Peter JB. The polymerase chain reaction: amplifying our options. Rev Infect Dis 1991;13:166-71.
82. Diagnosis of Duchenne and Becker muscular dystrophies by polymerase chain reaction: a multicenter study. JAMA 1992; 267:2609-15.
83. Fujimura FK. Cystic fibrosis gene analysis: recent diagnostic applications. Clin Biochem 1991;24:353-61.
84. Jass JR, Cottier DS, Jeevaratnam P, et al. Diagnostic use of microsatellite instability in hereditary non-polyposis colorectal cancer. Lancet 1995;346:1200-1.
85. Plummer SJ, Anton-Culver H, Webster L, et al. Detection of BRCA1 mutations by the protein truncation test. Hum Mol Genet 1995;4:1989-91.
86. Mahley RW, Innerarity TL, Rail SC Jr, et al. Apolipoprotein E: genetic variants provide insights into its structure and function. Curr Opin Lipidol 1990;1:87-95.
87. Zannis VI, Breslow JL. Human very low density lipoprotein apolipoprotein E isoprotein polymorphism is explained by genetic variation and posttranslational modification. Biochemistry 1981;20:1033-41.
88. Boerwinkle E, Utermann G. Simultaneous effects of the apolipoprotein E polymorphism on apolipoprotein E, apolipoprotein B, and cholesterol metabolism. Am J Hum Genet 1988;42:104-12.
89. Hallman DM, Boerwinkle E, Saha N, et al. The apolipoprotein E polymorphism: a comparison of allele frequencies and effects in nine populations. Am J Hum Genet 1991;49: 338-49.
90. Davignon J, Gregg RE, Sing CF. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 1988;8:1-21.
91. Menzel HJ, Kladetzky RG, Assmann G. Apolipoprotein E polymorphism and coronary artery disease. Arteriosclerosis 1983;3:310-15.
92. Lenzen HJ, Assmann G, Buchwalsky R, et al. Association of apolipoprotein E polymorphism, low-density lipoprotein cholesterol, and coronary artery disease. Clin Chem 1986; 32:778-81.
93. Nieminen MS, Mattila KJ, Aalto-Setälä K, et al. Lipoproteins and their genetic variation in subjects with and without angiographically verified coronary artery disease. Arterioscler Thromb 1992;12:58-69.
94. Stengård JH, Zerba KE, Pekkanen J, et al. Apolipoprotein E polymorphism predicts death from coronary heart disease in a longitudinal study of elderly Finnish men. Circulation 1995;91:265-9.
95. Szabo CI, King MC. Inherited breast and ovarian cancer. Hum Mol Genet 1995;4(spec no):1811-17.
96. Miki Y, Swensen J, Shattuck-Eidens D, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994;266:66-71.
97. Wooster R, Bignell G, Lancaster J, et al. Identification of the breast cancer susceptibility gene BRCA2. Nature 1995;378: 789-92.
98. Collins FS. BRCA1-lots of mutations, lots of dilemmas. (Editorial). N Engl J Med 1996;334:186-8.
99. Kahn P. Coming to grips with genes and risk. (News). Science 1996;274:496-8.
100. Durfy SJ. Ethics and the Human Genome Project. Arch Pathol Lab Med 1993;117:466-9.
101. Marshall E. The genome project's conscience. (News). Science 1996;274:488-90.
102. Verlinsky Y, Pergament E, Strom C. The preimplantation genetic diagnosis of genetic diseases. J In Vitro Fert Embryo Transf 1990;7:1-5.
103. Grody WW. Molecular genetics: introduction. Arch Pathol Lab Med 1993;117:470-2.